Skip to main content

Month: January 2023

Plains All American Pipeline and Plains GP Holdings Announce Timing of Fourth-Quarter and Full-Year 2022 Earnings

HOUSTON, Jan. 09, 2023 (GLOBE NEWSWIRE) — Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) announced they will release fourth-quarter and full-year 2022 earnings after market close on Wednesday, February 8, 2023 and will hold a joint webcast on the same day as follows: What: Fourth-quarter and Full-Year 2022 earnings webcast When: Wednesday, February 8, 2023 5:30 p.m. ET; 4:30 p.m. CT Where: www.plains.com or https://edge.media-server.com/mmc/p/igr8sbqe How: Live over the internet – log on at either of the addresses above Specific items we intend to address on the call include:PAA’s fourth-quarter and full-year 2022 performance; Capitalization and liquidity; and 2023 Financial guidanceThe slide presentation accompanying the conference call materials will be posted prior to the call...

Continue reading

Applied Digital Reports Fiscal Second Quarter 2023 Financial Results and Provides an Operational Update

Generated Sequential Revenue Growth of 78% DALLAS, Jan. 09, 2023 (GLOBE NEWSWIRE) — Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”), a designer, builder and operator of next-generation digital infrastructure that is designed for High Performance Computing (“HPC”) applications, today reported financial results for the fiscal second quarter of 2023 ended November 30, 2022. The Company also provided an operational update and outlook. Recent Operational and Financial HighlightsFiscal second quarter 2023 revenue of $12.3 million Fiscal second quarter 2023 adjusted EBITDA of $(2.1) million 100-Megawatt (“MW”) facility in Jamestown, North Dakota operated at full capacity during the quarter Changed name to “Applied Digital Corporation” through successful shareholder vote on November...

Continue reading

Accolade Announces Results for Fiscal Third Quarter 2023

Fiscal third quarter 2023 revenue of $90.9 million, a 9% increase compared to fiscal third quarter 2022 revenue of $83.5 million SEATTLE, Jan. 09, 2023 (GLOBE NEWSWIRE) — Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal third quarter ended November 30, 2022. “Accolade enters the new year having just concluded one of the strongest selling performances in our company’s history. Notably, the strength in our business is driven by the increasing diversity in our platform across solutions, customer types, distribution channels, and industry sectors. Accolade is leading the conversation with customers because of our proven track record of delivering measurable improvements in health and cost outcomes, and because our solutions are Engineered to Care,” said Rajeev Singh, Accolade Chief Executive Officer. “Innovations...

Continue reading

Revive Therapeutics Announces Publication Showing Bucillamine’s Potential Impact on COVID-19 Omicron Variants

TORONTO, Jan. 09, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announces an independent published study, titled “Omicron Spike Protein Is Vulnerable to Reduction” from the University of Toronto, which evaluated the potential disruption of the SARS-CoV-2 virus spike protein by various FDA-approved mild anti-oxidants has shown that Bucillamine had the most potent effect on COVID-19 Omicron variants when compared to these anti-oxidants being explored as a potential treatment for COVID-19. Disruption of the spike protein to prevent viral entry into the host cells with a molecule that is already approved and deemed safe for human use...

Continue reading

Firm Capital Mortgage Investment Corporation Confirmation of Special Year-End Dividend Amount

TORONTO, Jan. 09, 2023 (GLOBE NEWSWIRE) — Firm Capital Mortgage Investment Corporation (the “Corporation”) (TSX: FC) is pleased to confirm that its board of directors has formally declared the previously announced special year-end dividend of $0.014 per common share. The regular December 2022 dividend and the special year-end dividend, totalling $0.092 per common share, are payable on January 16, 2023, to holders of common shares of record at the close of business on December 31, 2022. The special year-end dividend recognizes that the annual income generated in 2022 exceeded the regular dividends. Accordingly, a special year-end dividend is being made to distribute all of the Corporation’s net income earned in 2022. The special dividend is not indicative of future performance by the Corporation. Total dividends paid...

Continue reading

Oak Valley Community Bank Receives Multiple SBA and Valley Small Business Lending Accolades

OAKDALE, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) — Oak Valley Community Bank, a wholly-owned subsidiary of Oak Valley Bancorp (NASDAQ: OVLY), was recognized by both Success Capital – Certified Development Corporation as their “Most Active SBA 504 Lending Partner” and by the Valley Small Business Development Corporation for the “Most Loan Guarantees Funded & Largest Total Dollar Aggregate Funded” during the most recent Success Capital and Valley Small Business fiscal years. Oak Valley’s team booked $13 million in SBA 504 loans through Success Capital, which helped fund $27 million in total projects, aiding in the creation or retention of nearly 100 small business jobs. This award marks the seventh consecutive year that Oak Valley Community Bank has won the “Most Active SBA 504 Lending Partner” award. In addition, Senior Vice...

Continue reading

Nokia Corporation: Repurchase of own shares on 09.01.2023

Nokia CorporationStock Exchange Release9 January 2023 at 21:00 EET Nokia Corporation: Repurchase of own shares on 09.01.2023 Espoo, Finland – On 9 January 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 228,553 4.57CEUX 23,679 4.58AQEU 10,017 4.60TQEX 2,751 4.58Total 265,000 4.58* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU)...

Continue reading

Selectis Health Reports Third Quarter 2022 Results

– Q3 2022 Revenue Increases 31% Year-over-Year to $9.6 Million – Greenwood Village, Colorado, Jan. 09, 2023 (GLOBE NEWSWIRE) — Selectis Health, Inc. (OTC: GBCS) (“Selectis” or the “Company”) is reporting financial and operating results for the third quarter ended September 30, 2022. Third Quarter 2022 Summary (vs. Year-Ago Quarter) 1Revenue increased 31% to $9.6 million compared to $7.3 million. Net loss was $1.0 million or $(0.33) per share compared to a net loss of $0.06 million or $(0.02) per share.“During the third quarter, we continued to advance our strategic initiatives and meaningfully increase our portfolio-wide patient census,” said Lance Baller, Chairman and CEO of Selectis. “We generated revenue growth of 31% year-over-year, even as we navigated the effects of seasonality and...

Continue reading

PETVIVO HOLDINGS, INC. TO EXHIBIT AT VETERINARY MEETING AND EXPO CONFERENCE IN ORLANDO, FLORIDA

MINNEAPOLIS, Jan. 09, 2023 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (“PetVivo”) an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals today announced it will be exhibiting at the Veterinary Meeting & Expo Conference from January 14th to January 18th, 2023 at the Orange County Convention Center in Orlando, FL. The Company’s management is excited to meet with many of the 10,000+ participants to introduce its lead product, Spryng™ with OsteoCushion™ Technology, a veterinary medical device injection of sterilized, naturally-derived hydrogel microparticles that are wet, slippery and spongy used in the management of lameness and other joint related afflictions, such as osteoarthritis. VMX is...

Continue reading

ADT Appoints Wayne Thorsen to Chief Business Officer Role

BOCA RATON, Fla., Jan. 09, 2023 (GLOBE NEWSWIRE) — ADT (NYSE: ADT) today announced the appointment of Wayne Thorsen to the newly created role of Executive Vice President and Chief Business Officer, effective immediately. Thorsen will be responsible for leading ADT’s product, innovation and new business development teams. “Wayne is a seasoned executive who brings valuable experience in business development, strategic partnerships and product marketing and development,” said Jim DeVries, ADT President and CEO. “Wayne’s expertise will accelerate our strategy to sustainably grow our business and continue to attract strategic partners by showcasing ADT’s market leadership.” “ADT’s innovation and strategic partnerships with fellow marquee brands, like State Farm and Google, are creating fantastic value that consumers are seeking from...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.